A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Multicenter Observational Study

T-DM1 EFFICACY AND ACTIVITY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PROGRESSING AFTER FRONTLINE TAXANE PLUS PERTUZUMAB AND TRASTUZUMAB: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY OF THE GRUPPO ITALIANO MAMMELLA (GIM) STUDY GROUP

The Breast ◽

10.1016/s0960-9776(19)30674-5 ◽

2019 ◽

Vol 48 ◽

pp. S45

Author(s):

Benedetta Conte ◽

Alessandra Fabi ◽

Francesca Poggio ◽

Eva Blondeaux ◽

Chiara Dellepiane ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Study Group ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Multicenter Observational Study

PO54 A RETROSPECTIVE MULTICENTER OBSERVATION STUDY IN METASTATIC BREAST CANCER PATIENTS: COMPARATIVE ANALYSIS ON EFFICACY OF ERIBULIN MESYLATE WITH TAXANE REGIMENS (INCLUDING COMBINATION WITH BEVACIZUMAB)

The Breast ◽

10.1016/s0960-9776(15)30066-7 ◽

2015 ◽

Vol 24 ◽

pp. S40

Author(s):

Yasuko Kikuchi ◽

Kazuo Shirakawa ◽

Hajime Kanauchi ◽

Takako Wakeda ◽

Takayoshi Niwa ◽

...

Keyword(s):

Breast Cancer ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Observation Study ◽

Eribulin Mesylate

P5-19-02: Comparison of the Incidence of Peripheral Neuropathy with Eribulin Mesylate Versus Ixabepilone in Metastatic Breast Cancer Patients: A Randomized Phase II Study.

10.1158/0008-5472.sabcs11-p5-19-02 ◽

2011 ◽

Author(s):

L Vahdat ◽

P Gopalakrishna ◽

AA Garcia ◽

C Vogel ◽

C Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Randomized Phase Ii

Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

International Journal of Cancer ◽

10.1002/ijc.32402 ◽

2019 ◽

Vol 145 (12) ◽

pp. 3359-3369 ◽

Cited By ~ 5

Author(s):

William Jacot ◽

Pierre‐Etienne Heudel ◽

Julien Fraisse ◽

Sophie Gourgou ◽

Séverine Guiu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Real Life ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Life Activity ◽

Eribulin Mesylate

474 First results of an international, retrospective observational study of metastatic breast cancer patients treated with oral vinorelbine based-chemotherapy

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70495-x ◽

2010 ◽

Vol 8 (3) ◽

pp. 197-198 ◽

Author(s):

A. Garcia Palomo ◽

H. Sommer ◽

N. Malamos ◽

I. Glogowska ◽

E. Kilar ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Retrospective Observational Study ◽

Breast Cancer Patients ◽

Oral Vinorelbine ◽

First Results

A broad Italian experience with eribulin mesylate in metastatic breast cancer patients: The ESEMPiO study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11539 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11539-e11539 ◽

Author(s):

Sandro Barni ◽

Caterina Fontanella ◽

Lucia Del Mastro ◽

Luca Livraghi ◽

Laura Pizzuti ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Italian Experience

1873 A retrospective multicenter observation study about comparative analysis on efficacy of eribulin mesylate with taxane regimens (including combination with bevacizumab) in metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(16)30823-1 ◽

2015 ◽

Vol 51 ◽

pp. S290 ◽

Author(s):

Y. Kikuchi ◽

K. Shirakawa ◽

H. Kanauchi ◽

T. Wakeda ◽

T. Niwa ◽

...

Keyword(s):

Breast Cancer ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Observation Study ◽

Eribulin Mesylate

P5-14-22: Prospective Observational Study To Describe the Clinicopathological and Biological Characteristics and the Management of Metastatic Breast Cancer Patients Who Experienced Complete or Partial Remission or Disease Stabilization during at Least 3 Years.

10.1158/0008-5472.sabcs11-p5-14-22 ◽

2011 ◽

Author(s):

P Zamora ◽

R Pérez-Carrión ◽

L Manso ◽

C Crespo ◽

C Mendiola ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Partial Remission ◽

Prospective Observational Study ◽

Metastatic Breast ◽

Biological Characteristics ◽

Breast Cancer Patients ◽

Disease Stabilization

Eribulin mesylate in heavily pretreated metastatic breast cancer patients: current practice in an Italian community hospital

Future Oncology ◽

10.2217/fon.13.251 ◽

2014 ◽

Vol 10 (2) ◽

pp. 233-239 ◽

Cited By ~ 15

Author(s):

Paola Poletti ◽

Valentina Ghilardi ◽

Luca Livraghi ◽

Laura Milesi ◽

Elena Rota Caremoli ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Current Practice ◽

Community Hospital ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Heavily Pretreated ◽

Italian Community

ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study

Future Oncology ◽

10.2217/fon-2017-0062 ◽

2017 ◽

Vol 13 (17) ◽

pp. 1517-1525 ◽

Cited By ~ 3

Author(s):

Luca Moscetti ◽

Lucia Mentuccia ◽

Patrizia Vici ◽

Silvia Quadrini ◽

Isabella Sperduti ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients